Comparison of SILAC and mTRAQ quantification for phosphoproteomics on a quadrupole orbitrap mass spectrometer

Journal of Proteome Research

Volumn 12, Issue 9, 2013, Pages 4089-4100

  Oppermann, Felix S ^a   Klammer, Martin ^a   Bobe, Caroline ^a   Cox, Jürgen ^b   Schaab, Christoph ^a,b   Tebbe, Andreas ^a   Daub, Henrik ^a  

^a Evotec München GmbH Dept of Bioinformatics   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

crizotinib; mTRAQ; phosphoproteomics; Q Exactive; SILAC

Indexed keywords

CRIZOTINIB; GUANOSINE TRIPHOSPHATASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPEPTIDE; PHOSPHOPROTEIN; PHOSPHOTRANSFERASE INHIBITOR;

ARTICLE; BIOINFORMATICS; CANCER CELL; CHEMICAL LABELING; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; ISOTOPE LABELING; LEUKEMIA CELL; LUNG CANCER; MASS SPECTROMETER; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUADRUPOLE ORBITRAP MASS SPECTROMETER; QUALITATIVE ANALYSIS;

HUMANS; ISOTOPE LABELING; K562 CELLS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN INTERACTION MAPS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS; PYRAZOLES; PYRIDINES; TANDEM MASS SPECTROMETRY;

EID: 84883751039     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400417g     Document Type: Article

References (46)

1. Grimsrud, P. A.; Swaney, D. L.; Wenger, C. D.; Beauchene, N. A.; Coon, J. J. Phosphoproteomics for the masses ACS Chem. Biol. 2010, 5 (1) 105-119
2. Schreiber, T. B.; Mausbacher, N.; Breitkopf, S. B.; Grundner-Culemann, K.; Daub, H. Quantitative phosphoproteomics-an emerging key technology in signal-transduction research Proteomics 2008, 8 (21) 4416-4432
3. Nikolov, M.; Schmidt, C.; Urlaub, H. Quantitative mass spectrometry-based proteomics: An overview Methods Mol. Biol. 2012, 893, 85-100
4. Bantscheff, M.; Schirle, M.; Sweetman, G.; Rick, J.; Kuster, B. Quantitative mass spectrometry in proteomics: A critical review Anal. Bioanal. Chem. 2007, 389 (4) 1017-1031
5. Ong, S. E. The expanding field of SILAC Anal. Bioanal. Chem. 2012, 404 (4) 967-976
6. Olsen, J. V.; Blagoev, B.; Gnad, F.; Macek, B.; Kumar, C.; Mortensen, P.; Mann, M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks Cell 2006, 127 (3) 635-648
7. Rigbolt, K. T.; Prokhorova, T. A.; Akimov, V.; Henningsen, J.; Johansen, P. T.; Kratchmarova, I.; Kassem, M.; Mann, M.; Olsen, J. V.; Blagoev, B. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation Sci. Signaling 2011, 4 (164) rs3
8. Mäusbacher, N.; Schreiber, T. B.; Machatti, M.; Schaab, C.; Daub, H. Proteome-wide analysis of temporal phosphorylation dynamics in lysophosphatidic acid-induced signaling Proteomics 2012, 12 (23-24) 3485-3498
9. Evans, C.; Noirel, J.; Ow, S. Y.; Salim, M.; Pereira-Medrano, A. G.; Couto, N.; Pandhal, J.; Smith, D.; Pham, T. K.; Karunakaran, E.; Zou, X.; Biggs, C. A.; Wright, P. C. An insight into iTRAQ: where do we stand now? Anal. Bioanal. Chem. 2012, 404 (4) 1011-1027
10. Ting, L.; Rad, R.; Gygi, S. P.; Haas, W. MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics Nat. Methods 2011, 8 (11) 937-940
11. Wenger, C. D.; Lee, M. V.; Hebert, A. S.; McAlister, G. C.; Phanstiel, D. H.; Westphall, M. S.; Coon, J. J. Gas-phase purification enables accurate, multiplexed proteome quantification with isobaric tagging Nat. Methods 2011, 8 (11) 933-935
12. Michalski, A.; Damoc, E.; Hauschild, J. P.; Lange, O.; Wieghaus, A.; Makarov, A.; Nagaraj, N.; Cox, J.; Mann, M.; Horning, S. Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer Mol. Cell. Proteomics 2011, 10 (9) M111 011015
13. Kelstrup, C. D.; Young, C.; Lavallee, R.; Nielsen, M. L.; Olsen, J. V. Optimized Fast and Sensitive Acquisition Methods for Shotgun Proteomics on a Quadrupole Orbitrap Mass Spectrometer J. Proteome Res. 2012, 11, 3487-3497
14. Wuhr, M.; Haas, W.; McAlister, G. C.; Peshkin, L.; Rad, R.; Kirschner, M. W.; Gygi, S. P. Accurate multiplexed proteomics at the MS2 level using the complement reporter ion cluster Anal. Chem. 2012, 84 (21) 9214-9221
15. Boersema, P. J.; Raijmakers, R.; Lemeer, S.; Mohammed, S.; Heck, A. J. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics Nat. Protoc. 2009, 4 (4) 484-494
16. Kang, U. B.; Yeom, J.; Kim, H.; Lee, C. Quantitative analysis of mTRAQ-labeled proteome using full MS scans J. Proteome Res. 2010, 9 (7) 3750-3758
17. Altelaar, A. F.; Frese, C. K.; Preisinger, C.; Hennrich, M. L.; Schram, A. W.; Timmers, H. T.; Heck, A. J.; Mohammed, S. Benchmarking stable isotope labeling based quantitative proteomics J. Proteomics 2012, 88, 14-26
18. DeSouza, L. V.; Romaschin, A. D.; Colgan, T. J.; Siu, K. W. Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer Anal. Chem. 2009, 81 (9) 3462-3470
19. Villen, J.; Gygi, S. P. The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry Nat. Protoc. 2008, 3 (10) 1630-1638
20. Oppermann, F. S.; Grundner-Culemann, K.; Kumar, C.; Gruss, O. J.; Jallepalli, P. V.; Daub, H. Combination of chemical genetics and phosphoproteomics for kinase signaling analysis enables confident identification of cellular downstream targets Mol. Cell. Proteomics 2012, 11 (4) O111 012351
21. Cox, J.; Mann, M. MaxQuant enables high peptide identification rates, individualized ppb-range mass accuracies and proteome-wide protein quantification Nat. Biotechnol. 2008, 26 (12) 1367-1372
22. Cox, J.; Neuhauser, N.; Michalski, A.; Scheltema, R. A.; Olsen, J. V.; Mann, M. Andromeda: A peptide search engine integrated into the MaxQuant environment J. Proteome Res. 2011, 10 (4) 1794-1805
23. Daub, H.; Olsen, J. V.; Bairlein, M.; Gnad, F.; Oppermann, F. S.; Korner, R.; Greff, Z.; Keri, G.; Stemmann, O.; Mann, M. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle Mol. Cell 2008, 31 (3) 438-448
24. Schaab, C. Analysis of phosphoproteomics data Methods Mol. Biol. 2011, 696, 41-57
25. Zhou, Y.; Cras-Meneur, C.; Ohsugi, M.; Stormo, G. D.; Permutt, M. A. A global approach to identify differentially expressed genes in cDNA (two-color) microarray experiments Bioinformatics 2007, 23 (16) 2073-2079
26. Schaab, C.; Geiger, T.; Stoehr, G.; Cox, J.; Mann, M. Analysis of high accuracy, quantitative proteomics data in the MaxQB database Mol. Cell. Proteomics 2012, 11 (3) M111 014068
27. Klammer, M.; Godl, K.; Tebbe, A.; Schaab, C. Identifying differentially regulated subnetworks from phosphoproteomic data BMC Bioinformatics 2010, 11, 351
28. Szklarczyk, D.; Franceschini, A.; Kuhn, M.; Simonovic, M.; Roth, A.; Minguez, P.; Doerks, T.; Stark, M.; Muller, J.; Bork, P.; Jensen, L. J.; von Mering, C. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored Nucleic Acids Res. 2011, 39 (Database issue) D561-D568
29. Mertins, P.; Udeshi, N. D.; Clauser, K. R.; Mani, D. R.; Patel, J.; Ong, S. E.; Jaffe, J. D.; Carr, S. A. iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics Mol. Cell. Proteomics 2012, 11 (6) M111 014423
30. Thingholm, T. E.; Palmisano, G.; Kjeldsen, F.; Larsen, M. R. Undesirable charge-enhancement of isobaric tagged phosphopeptides leads to reduced identification efficiency J. Proteome Res. 2010, 9 (8) 4045-4052
31. Sasaki, T.; Koivunen, J.; Ogino, A.; Yanagita, M.; Nikiforow, S.; Zheng, W.; Lathan, C.; Marcoux, J. P.; Du, J.; Okuda, K.; Capelletti, M.; Shimamura, T.; Ercan, D.; Stumpfova, M.; Xiao, Y.; Weremowicz, S.; Butaney, M.; Heon, S.; Wilner, K.; Christensen, J. G.; Eck, M. J.; Wong, K. K.; Lindeman, N.; Gray, N. S.; Rodig, S. J.; Janne, P. A. A novel ALK sondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors Cancer Res. 2011, 71 (18) 6051-6060
32. Ou, S. H.; Bartlett, C. H.; Mino-Kenudson, M.; Cui, J.; Iafrate, A. J. Crizotinib for the Treatment of ALK-Rearranged Non-Small Cell Lung Cancer: A Success Story to Usher in the Second Decade of Molecular Targeted Therapy in Oncology Oncologist 2012, 17, 1351-1375
33. Jensen, L. J.; Kuhn, M.; Stark, M.; Chaffron, S.; Creevey, C.; Muller, J.; Doerks, T.; Julien, P.; Roth, A.; Simonovic, M.; Bork, P.; von Mering, C. STRING 8-a global view on proteins and their functional interactions in 630 organisms Nucleic Acids Res. 2009, 37 (suppl-1) D412-416
34. Katayama, R.; Khan, T. M.; Benes, C.; Lifshits, E.; Ebi, H.; Rivera, V. M.; Shakespeare, W. C.; Iafrate, A. J.; Engelman, J. A.; Shaw, A. T. Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (18) 7535-7540
35. Bauer, D. E.; Hatzivassiliou, G.; Zhao, F.; Andreadis, C.; Thompson, C. B. ATP citrate lyase is an important component of cell growth and transformation Oncogene 2005, 24 (41) 6314-6322
36. Wang, L.; Harris, T. E.; Lawrence, J. C., Jr. Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation J. Biol. Chem. 2008, 283 (23) 15619-15627
37. Feng, J.; Tamaskovic, R.; Yang, Z.; Brazil, D. P.; Merlo, A.; Hess, D.; Hemmings, B. A. Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation J. Biol. Chem. 2004, 279 (34) 35510-35517
38. Hayakawa, J.; Ohmichi, M.; Kurachi, H.; Kanda, Y.; Hisamoto, K.; Nishio, Y.; Adachi, K.; Tasaka, K.; Kanzaki, T.; Murata, Y. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin Cancer Res. 2000, 60 (21) 5988-5994
39. Cai, S. L.; Tee, A. R.; Short, J. D.; Bergeron, J. M.; Kim, J.; Shen, J.; Guo, R.; Johnson, C. L.; Kiguchi, K.; Walker, C. L. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning J. Cell Biol. 2006, 173 (2) 279-289
40. Tao, Z.; Barker, J.; Shi, S. D.; Gehring, M.; Sun, S. Steady-state kinetic and inhibition studies of the mammalian target of rapamycin (mTOR) kinase domain and mTOR complexes Biochemistry 2010, 49 (39) 8488-8498
41. Oshiro, N.; Takahashi, R.; Yoshino, K.; Tanimura, K.; Nakashima, A.; Eguchi, S.; Miyamoto, T.; Hara, K.; Takehana, K.; Avruch, J.; Kikkawa, U.; Yonezawa, K. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1 J. Biol. Chem. 2007, 282 (28) 20329-20339
42. Lovly, C. M.; Heuckmann, J. M.; de Stanchina, E.; Chen, H.; Thomas, R. K.; Liang, C.; Pao, W. Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors Cancer Res. 2010, 71 (14) 4920-4931
43. Sears, R.; Nuckolls, F.; Haura, E.; Taya, Y.; Tamai, K.; Nevins, J. R. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability Genes Dev. 2000, 14 (19) 2501-2514
44. Hwang, J. H.; Kim, D. W.; Suh, J. M.; Kim, H.; Song, J. H.; Hwang, E. S.; Park, K. C.; Chung, H. K.; Kim, J. M.; Lee, T. H.; Yu, D. Y.; Shong, M. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation Mol. Endocrinol. 2003, 17 (6) 1155-1166
45. Monetti, M.; Nagaraj, N.; Sharma, K.; Mann, M. Large-scale phosphosite quantification in tissues by a spike-in SILAC method Nat. Methods 2011, 8 (8) 655-658
46. Geiger, T.; Cox, J.; Ostasiewicz, P.; Wisniewski, J. R.; Mann, M. Super-SILAC mix for quantitative proteomics of human tumor tissue Nat. Methods 2010, 7 (5) 383-385